Initiatives to Promote Charity, Leadership Appointments, Acquisition Agreements, and Technical Updates - Research Reports on Rite Aid, WellPoint, UHS, Cameron and Nucor

NEW YORK, September 18, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Rite Aid Corporation (NYSE: RAD), WellPoint Inc. (NYSE: WLP), Universal Health Services Inc. (NYSE: UHS), Cameron International Corporation (NYSE: CAM) and Nucor Corporation (NYSE: NUE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6563-100free.

--
Rite Aid Corporation Research Reports
On September 15, 2014, Rite Aid Corporation (Rite Aid) announced that through its Rite Aid Foundation's Kidcents Program, its customers can select any charity they want to support from the 204 approved charities listed on its website. According to the release, customers can review and choose from the approved KidCents charities, and once selected, their subsequent purchase at Rite Aid will be rounded up to the nearest dollar and the change will be designated to their selected charity. Marking the occasion, Rite Aid said that its associates across the country will present checks of $10,000 to each of the 204 inaugural KidCents charities, totaling over $2 million in donations, during the week. The full research reports on Rite Aid are available to download free of charge at:

http://www.analystsreview.com/Sep-18-2014/RAD/report.pdf

--
WellPoint Inc. Research Reports
On September 15, 2014, shares of WellPoint Inc. (WellPoint) fell 0.19% from its previous day's close to end the trading session at $118.40. The stock opened at $118.65 and moved in the range of $118.01 - $119.11. A total of 1.32 million shares were traded, lower than its 30-day average trading volume of 1.55 million shares. The stock is trading near its 52-week high of $121.33, which it made on September 9, 2014. Additionally, the Company's stock closed above its 50-day and 200-day moving averages of $113.22 and $99.76, respectively. During the last one month the stock has gained 5.92% compared to NYSE Composite that gained 1.05% during the same trading period, while year-till-date, the stock has returned 28.15%, significantly outperforming the NYSE Composite, which returned 4.89%, over the same time period. The full research reports on WellPoint are available to download free of charge at:

http://www.analystsreview.com/Sep-18-2014/WLP/report.pdf

--
Universal Health Services Inc. Research Reports
On September 15, 2014, Universal Health Services Inc.'s (UHS) stock fell 0.41%, to close the day at $111.25. After opening at $112.43, the shares moved in the range of $110.22-$113.21. The Company recorded a trading volume of 1.3 million shares, above its 30-day average trading volume of 0.72 million. Also, the shares closed above their 50-day and 200-day moving averages of $33.29 and $27.87, respectively. Year to date the stock has returned 36.91%, compared to NYSE composite that has gained 4.89% over the same duration. The full research reports on UHS are available to download free of charge at:

http://www.analystsreview.com/Sep-18-2014/UHS/report.pdf

--
Cameron International Corporation Research Reports
On September 11, 2014, Cameron International Corporation (Cameron) announced that Scott Rowe will take the newly created role of President and Chief Operating Officer of the Company, effective October 1, 2014. Mr. Rowe, who will report directly to the Company's Chairman and CEO Jack Moore, has served Cameron for 12 years, most recently as the CEO of OneSubsea - a JV between the Company and Schlumberger. He has also served as the President of the Company's Subsea Systems division and Engineered and Process Valves business in its Valves and Measurement segment. Jack Moore said, "Scott has led significant parts of our operations for the past six years in two of our segments. His proven track record in improving the operations in each of those segments will serve Cameron well as we continue to drive our multi-year margin expansion program." The full research reports on Cameron are available to download free of charge at:

http://www.analystsreview.com/Sep-18-2014/CAM/report.pdf

--
Nucor Corporation Research Reports
On September 15, 2014, Nucor Corporation (Nucor) announced that it has entered into an agreement to purchase all the equity of Gallatin Steel Company (Gallatin) for a cash purchase price of approximately $770 million. Nucor added that after adjusting for the net present value of the anticipated tax benefits, the realized effective purchase price is approximately $630 million. According to the Company, the acquisition of the flat-rolled products mill will increase Nucor's total flat-rolled product annual capacity by 16% - to approximately 13 million tons. The acquisition will be funded with available cash and commercial paper borrowings, the Company informed. John Ferriola, Chairman, CEO and President of Nucor said, "Our agreement to purchase Gallatin Steel is a significant step forward in the execution of Nucor's strategy for profitable growth." "We believe this transaction will create excellent value for our shareholders, as the purchase price represents a multiple of approximately 6.4 times estimated 2015 EBITDA before synergies and approximately 5.3 times estimated 2015 EBITDA before synergies net of anticipated tax benefits," he added. The full research reports on Nucor are available to download free of charge at:

http://www.analystsreview.com/Sep-18-2014/NUE/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review